Related Experiment Videos
Psoriasis, razoxane and a cutaneous B-cell lymphoma
The British Journal of Dermatology
|February 1, 1987
Summary
A patient with a long history of pustular psoriasis developed lip lymphoma after razoxane treatment. This case highlights a potential association between razoxane and B-cell lymphoma in psoriasis patients.
Area of Science:
- Dermatology
- Oncology
- Pharmacology
Background:
- Acral pustular psoriasis of Hallopeau is a rare, chronic skin condition.
- Razoxane is a medication sometimes used in dermatological treatments.
Observation:
- A patient with a 20-year history of acral pustular psoriasis presented with recurrent pustular lesions.
- The patient underwent 4 1/2 years of treatment with razoxane.
Findings:
- Following razoxane therapy, the patient developed a B-cell lymphoma of the lip.
- This suggests a potential link between razoxane and lymphomagenesis in this context.
Implications:
- This case underscores the importance of monitoring for secondary malignancies in patients undergoing long-term dermatological treatments.
- Further research is warranted to investigate the potential oncogenic risk of razoxane in psoriasis management.